The Lancet Infectious Diseases

This article aims to investigate the effectiveness of a booster (third dose) vaccination against severe, critical, or fatal COVID-19, relative to that of primary-series (two-dose) vaccination over a follow-up duration of 1 year among patients in Qatar.

Journal Article